GLOBAL STEM CELL MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • GLOBAL STEM CELL MARKET FORECAST 2018-2026

GLOBAL STEM CELL MARKET FORECAST 2018-2026

The Global Stem Cell market is anticipated to grow at a CAGR of 9.73% between 2018 and 2026. Stem cells hold a potential to develop into many different types of cells in the body. They serve as a repair system for the body. The Stem Cell market is primarily driven by the following factors: Potential of stem cells in regenerative medicine. Key to anti-ageing and prolonging life. Increasing R&D investments in adult stem cell research

GLOBAL STEM CELL MARKET FORECAST 2018-2026

Global Stem Cell Market by Products (Adult Stem Cell Market, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell Market, Rat Neural Stem Cell Market) by Technology(Stem Cell Acquisition Market, Stem Cell Production Market, Stem Cell Cryopreservation Market, Stem Cells Expansion and Sub-culture Market) by Application(Stem Cells Regenerative Medicine Market, Drug Discovery and Development Market) & by Geography

Request free sample

The Global Stem Cell market is anticipated to grow at a CAGR of 9.73% between 2018 and 2026. Stem cells hold a potential to develop into many different types of cells in the body. They serve as a repair system for the body. The Stem Cell market is primarily driven by the following factors:

  • Potential of stem cells in regenerative medicine
  • Key to anti-ageing and prolonging life
  • Increasing R&D investments in adult stem cell research
  • Ease of administration
  • Reduced risk of tissue rejection in transplants
  • Federal funding for stem cell research

Global Stem Cell Market

To learn more about this report, request a free sample copy

The important drivers increasing growth in the global stem cell market are potential of stem cells in regenerative medicine and them being a key to anti-aging and prolonging life. Regenerative medicine helps produce living, functional tissues to repair aged or diseased tissue; and is thus used in the treatment of cardiovascular, neural, orthopedic, and autoimmune diseases. Stem cell technology can replenish the body with young cells that have the ability to divide, differentiate, and replace old and damaged cells.

Stem Cell market products are widely used. Adult stem cells are found in adult bone marrow and cord blood tissues. Adult stem cell therapy currently forms about 60% of the stem cell market and is also expected to have a high growth potential in the coming years. Embryonic stem cell technology is tied up with many ethical, political, and religious controversies, as the stem cells can be obtained only after the destruction of a human embryo. Induced Pluripotent Stem Cell is derived from blood or skin cells that have been reprogrammed into an emergent-like pluripotent state, which allows the growth of an unlimited source of any type of human cell needed for therapeutic purposes. Rat Neural Stem Cells (RNSC) are multipotent and can be induced to differentiate into neurons, astrocytes, and oligodendrocytes that make up the central nervous system (CNS).

Safety and ethical issues are the major factors hindering the Stem Cell market’s growth. Safety issues concerning stem cells stored in banks need to be addressed to fully exploit the immense potential of stem cell therapy. The use of embryonic stem cells necessarily involves the destruction of the blastocyst and is thus considered a violation of human rights by those who believe that the embryo holds the right to live.

The global stem cell market segments include products, technologies, and applications.

  • Products are segmented into:
    • Adult stem cell market
      • Hematopoietic stem cell market
      • Mesenchymal stem cell market
      • Neural stem cell market
      • Dental stem cell market
      • Umbilical cord stem cell market
    • Human embryonic stem cell
    • Induced pluripotent stem cell market
    • Rat neural stem cell market
  • Technologies are segmented into:
    • Stem cell acquisition
      • Stem cell bone marrow market
      • Stem cell apheresis market
      • Umbilical cord blood market
    • Stem cell production
      • Therapeutic cloning
      • IVF stem cell
      • Stem cell culture
    • Stem cell cryopreservation
    • Stem cells expansion and sub-culture
  • Applications are segmented into:
    • Regenerative medicine
    • Drug discovery and development

This report covers the present market conditions and the growth prospects of the global stem cell market for 2018-2026 and considered the revenue generated through the sales of Stem Cell market for products, technologies, and applications to calculate the market size, by considering 2017 as the base year.

Geographically, the global stem cell market has been segmented on the basis of four major regions, which includes:

  • Stem Cell North America Market: The United States & Canada
  • Stem Cell Asia-Pacific Market: China, India, Japan, South Korea & Rest of APAC
  • Stem Cell Europe Market: The United Kingdom, France, Germany, Spain, Italy & Rest of Europe
  • Rest of World: Latin America, Middle East and North Africa & rest of Africa

The Stem Cell market in North America is expected to hold the largest share by 2026 owing to the increase in the number of cancer cases in both, males and females. Also, increased investment in the research and development activities in the field of stem cell and other pharmaceuticals is also propelling the growth of the stem cell market in North America. The United States has captured a significant share of North America’s stem cell market, and it is expected to be the fastest-growing market in the region. On the other hand, the Asia-Pacific is anticipated to be the fastest-growing region for the Stem Cell market. This market’s prosperity can be attributed to the developing economies in the region that are investing large amounts in medical research and healthcare facilities. The fact that there is an increase in incidences of chronic diseases like cancers in APAC is also driving the market demand. The stem cell market in the Asia Pacific will be one of the largest contributing markets in the near future.

The Stem Cell market is segmented based on technologies which are sub-divided into acquisition, production, cryopreservation, expansion, and sub-culture. The market is also segmented on the basis of applications which are sub-divided into regenerative medicine & drug discovery and development. Stem cell acquisition is the process wherein stem cells are procured from mature tissues such as bone marrow, peripheral blood, and umbilical cord blood through bone marrow harvest, apheresis, and umbilical cord stem cell acquisition respectively. Stem cell expansion and sub-culture involve growing the isolated cells in several flasks containing culture media. The growth in the stem cell applications market has been predominantly stimulated by the advent of regenerative medicines. Stem cell models offer new opportunities to improve the manner in which the pharmaceutical companies can identify lead candidates and bring new drugs to the market.

The major market players in the global stem cell market are:

  • Becton Dickinson
  • Ge Healthcare
  • Stemedica Cell Technologies Inc
  • Corning Inc
  • Thermo Fisher

Company Profiles covers analysis of important players.

Becton Dickinson Biosciences is a world leader in bringing innovative diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production and disease management. Thermo Fisher is a USA based company headquartered in Massachusetts. The company has four business segments: laboratory products & services, analytical instruments, specialty diagnostics and life sciences solutions.

Key Findings of the Global Stem Cell market:

  • Regenerative medicine is the emerging branch of medical science
  • Use of adult stem cells has been significant
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
    • ESTIMATION METHODOLOGY
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • REGENERATIVE MEDICINE IS THE EMERGING BRANCH OF MEDICAL SCIENCE
      • USE OF ADULT STEM CELLS HAS BEEN SIGNIFICANT
  1. MARKET DETERMINANTS
    • MARKET DRIVER
      • POTENTIAL OF STEM CELLS IN REGENERATIVE MEDICINE
      • KEY TO ANTI-AGEING AND PROLONGING LIFE
      • INCREASING R&D INVESTMENTS IN ADULT STEM CELL RESEARCH
      • EASE OF ADMINISTRATION
      • REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
      • FEDERAL FUNDING FOR STEM CELL RESEARCH
    • MARKET RESTRAINTS
      • SAFETY ISSUES
      • ETHICAL ISSUES
    • OPPORTUNITIES
      • TECHNOLOGICAL INNOVATIONS
      • EMERGING APPLICATION AS A DRUG DISCOVERY TOOL
      • OTHER PROMISING APPLICATIONS
    • MARKET CHALLENGES
      • STRINGENT GOVERNMENT REGULATIONS
      • LESS RESPONSIVENESS IN THE DEVELOPED ECONOMIES
  1. MARKET SEGMENTATION
    • MARKET BY PRODUCTS 2018-2026
      • ADULT STEM CELL MARKET
        • HEMATOPOIETIC STEM CELL MARKET
        • MESENCHYMAL STEM CELL MARKET
        • NEURAL STEM CELL MARKET
        • DENTAL STEM CELL MARKET
        • UMBILICAL CORD STEM CELL MARKET
      • HUMAN EMBRYONIC STEM CELL
      • INDUCED PLURIPOTENT STEM CELL MARKET
      • RAT NEURAL STEM CELL MARKET
    • MARKET BY TECHNOLOGY 2018-2026
      • STEM CELL ACQUISITION
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS MARKET
        • UMBILICAL CORD BLOOD MARKET
      • STEM CELL PRODUCTION
        • THERAPEUTIC CLONING
        • IVF STEM CELL
        • STEM CELL CULTURE
      • STEM CELL CRYOPRESERVATION
      • STEM CELLS EXPANSION AND SUB-CULTURE
    • MARKET BY APPLICATION 2018-2026
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • OPPORTUNITY MATRIX
    • KEY BUYING CRITERIA
      • HIGH PRICE
      • EFFICACY
      • APPLICATION AND EFFECTIVENESS
      • ACCURACY
    • STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
    • PEST ANALYSIS
    • HISTORY OF STEM CELL
    • PATENT ANALYSIS
      • STEM CELL PATENT IN NORTH AMERICA
      • STEM CELL PATENT IN EUROPE
      • STEM CELL PATENT IN ASIA PACIFIC
    • REGULATORY FRAMEWORK
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC (APAC)
      • INDIA
      • CHINA
      • JAPAN
      • SOUTH KOREA
      • REST OF ASIA PACIFIC (ROAPAC)
    • REST OF WORLD (ROW)
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
      • REST OF AFRICA
  1. COMPANY PROFILE
    • COMPETITIVE LANDSCAPE
      • MARKET SHARE ANALYSIS
    • BECTON DICKINSON
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • BIOTIME INC
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • BRAINSTORM CELL THERAPEUTICS
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • CELGENE CORPORATION
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • CELLULAR ENGINEERING TECHNOLOGIES INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • CORESTEM INC
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • CORNING INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • CYTORI THERAPEUTICS
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • FIBROCELL SCIENCE INC
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • GE HEALTHCARE
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • KANGSTEM BIOTECH LTD
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
    • STEMEDICA CELL TECHNOLOGIES INC
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
    • STRYKER CORPORATION
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • TAKARA HOLDINGS INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • THERMO FISHER
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • VERICEL CORPORATION (FORMERLY AASTROM BIOSCIENCE)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES

 

TABLE LIST

TABLE  1      GLOBAL STEM CELL MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  2      GLOBAL STEM CELLS MARKET BY PRODUCTS 2018-2026 ($ MILLION)

TABLE  3      GLOBAL STEM CELL MARKET IN ADULT STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  4      GLOBAL STEM CELL MARKET IN ADULT STEM CELL BY TYPES 2018-2026 ($ MILLION)

TABLE  5      GLOBAL ADULT STEM CELL MARKET IN HEMATOPOIETIC STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  6      GLOBAL ADULT STEM CELL MARKET IN MESENCHYMAL STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  7      GLOBAL ADULT STEM CELL MARKET IN NEURAL STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  8      GLOBAL ADULT STEM CELL MARKET IN DENTAL STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  9      GLOBAL ADULT STEM CELL MARKET IN UMBILICAL CORD STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  10    GLOBAL STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  11    GLOBAL STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  12    GLOBAL STEM CELL MARKET IN RAT NEURAL STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  13    GLOBAL STEM CELL MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)

TABLE  14    GLOBAL STEM CELL MARKET IN ACQUISITION BY TYPES 2018-2026 ($ MILLION)

TABLE  15    GLOBAL STEM CELL MARKET IN ACQUISITION BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  16    GLOBAL STEM CELL ACQUISITION MARKET IN BONE MARROW BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  17    GLOBAL STEM CELL ACQUISITION MARKET IN CELL APHERESIS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  18    GLOBAL STEM CELL ACQUISITION MARKET IN UMBILICAL CORD BLOOD BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  19    GLOBAL STEM CELL MARKET IN PRODUCTION BY TYPES 2018-2026 ($ MILLION)

TABLE  20    GLOBAL STEM CELL MARKET IN PRODUCTION BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  21    GLOBAL STEM CELL PRODUCTION MARKET IN THERAPEUTIC CLONING BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  22    GLOBAL STEM CELL PRODUCTION MARKET IN IVF STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  23    GLOBAL STEM CELL PRODUCTION MARKET IN STEM CELL CULTURE BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  24    GLOBAL STEM CELL MARKET IN STEM CELL CRYOPRESERVATION BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  25    GLOBAL STEM CELL MARKET IN STEM CELL EXPANSION AND SUB-CULTURE BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  26    GLOBAL STEM CELLS MARKET BY APPLICATION 2018-2026 ($ MILLION)

TABLE  27    GLOBAL STEM CELLS MARKET IN REGENERATIVE MEDICINE BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  28    GLOBAL STEM CELL MARKET IN DRUG DISCOVERY AND DEVELOPMENT BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE  29    GLOBAL STEM CELL MARKET BY GEOGRAPHY 2018-2026 (IN $ MILLION)

TABLE  30    NORTH AMERICA STEM CELL MARKET, BY COUNTRY, 2018-2026 (IN $ MILLION)

TABLE  31    EUROPE STEM CELL MARKET BY COUNTRY 2018-2026 (IN $ MILLION)

TABLE  32    ASIA PACIFIC STEM CELL MARKET BY COUNTRY 2018-2026 ($ MILLION)

TABLE  33    STEM CELL RESEARCH POLICIES IN SOME ASIAN COUNTRIES

TABLE  34    REST OF WORLD STEM CELL MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

 

FIGURES LIST

FIGURE  1    GLOBAL STEM CELL MARKET 2018-2026 ($ MILLION)

FIGURE  2    GLOBAL STEM CELL MARKET IN ADULT STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)

FIGURE  3    GLOBAL ADULT STEM CELL MARKET IN HEMATOPOIETIC STEM CELL 2018-2026 ($ MILLION)

FIGURE  4    GLOBAL ADULT STEM CELL MARKET IN MESENCHYMAL STEM CELL 2018-2026 ($ MILLION)

FIGURE  5    GLOBAL ADULT STEM CELL MARKET IN NEURAL STEM CELL 2018-2026 ($ MILLION)

FIGURE  6    GLOBAL ADULT STEM CELL MARKET IN DENTAL STEM CELL 2018-2026 ($ MILLION)

FIGURE  7    GLOBAL ADULT STEM CELL MARKET IN UMBILICAL CORD STEM CELL 2018-2026 ($ MILLION)

FIGURE  8    GLOBAL STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2018-2026 ($ MILLION)

FIGURE  9    GLOBAL STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2018-2026 ($ MILLION)

FIGURE  10  GLOBAL STEM CELL MARKET IN RAT NEURAL STEM CELL 2018-2026 ($ MILLION)

FIGURE  11  GLOBAL STEM CELL MARKET IN ACQUISITION 2018-2026 ($ MILLION)

FIGURE  12  GLOBAL STEM CELL ACQUISITION MARKET IN BONE MARROW 2018-2026 ($ MILLION)

FIGURE  13  GLOBAL STEM CELL ACQUISITION MARKET IN APHERESIS 2018-2026 ($ MILLION)

FIGURE  14  GLOBAL STEM CELL ACQUISITION MARKET IN UMBILICAL CORD BLOOD 2018-2026 ($ MILLION)

FIGURE  15  GLOBAL STEM CELL MARKET IN PRODUCTION 2018-2026 ($ MILLION)

FIGURE  16  GLOBAL STEM CELL PRODUCTION MARKET IN THERAPEUTIC CLONING 2018-2026 ($ MILLION)

FIGURE  17  GLOBAL STEM CELL PRODUCTION MARKET IN IVF STEM CELL 2018-2026 ($ MILLION)

FIGURE  18  GLOBAL STEM CELL PRODUCTION MARKET IN STEM CELLS CULTURE 2018-2026 ($ MILLION)

FIGURE  19  GLOBAL STEM CELL MARKET IN STEM CELLS CRYOPRESERVATION 2018-2026 ($ MILLION)

FIGURE  20  GLOBAL STEM CELL MARKET IN STEM CELL EXPANSION AND SUB-CULTURE 2018-2026 ($ MILLION)

FIGURE  21  GLOBAL STEM CELLS MARKET IN REGENERATIVE MEDICINE 2018-2026 ($ MILLION)

FIGURE  22  GLOBAL STEM CELL MARKET IN DRUG DISCOVERY AND DEVELOPMENT 2018-2026 ($ MILLION)

FIGURE  23  THE UNITED STATES STEM CELL MARKET 2018-2026 (IN $ MILLION)

FIGURE  24  CANADA STEM CELL MARKET 2018-2026 (IN $ MILLION)

FIGURE  25  THE UNITED KINGDOM STEM CELL MARKET 2018-2026 (IN $ MILLION)

FIGURE  26  FRANCE STEM CELL MARKET, 2018-2026 (IN $ MILLION)

FIGURE  27  GERMANY STEM CELL MARKET 2018-2026 (IN $ MILLION)

FIGURE  28  SPAIN STEM CELL MARKET 2018-2026 (IN $ MILLION)

FIGURE  29  ITALY STEM CELL MARKET 2018-2026 (IN $ MILLION)

FIGURE  30  REST OF EUROPE STEM CELL MARKET 2018-2026 (IN $ MILLION)

FIGURE  31  ASIA PACIFIC STEM CELL MARKET 2018-2026 ($ MILLION)

FIGURE  32  INDIA STEM CELL MARKET 2018-2026 ($ MILLION)

FIGURE  33  CHINA STEM CELL MARKET 2018-2026($ MILLION)

FIGURE  34  JAPAN STEM CELL MARKET 2018-2026 ($ MILLION)

FIGURE  35  SOUTH KOREA STEM CELL MARKET 2018-2026 ($ MILLION)

FIGURE  36  REST OF APAC STEM CELL MARKET 2018-2026($ MILLION)

FIGURE  37  REST OF WORLD STEM CELL MARKET 2018-2026 ($ MILLION)

FIGURE  38  LATIN AMERICA STEM CELL MARKET 2018-2026 ($ MILLION)

FIGURE  39  MIDDLE EAST & AFRICA STEM CELL MARKET 2018-2026 ($ MILLION)

FIGURE  40  REST OF AFRICA STEM CELL MARKET 2018-2026 ($ MILLION)

FIGURE  41  STEM CELL MARKET SHARE ANALYSIS OF KEY PLAYERS 2017 (%)

  1. MARKET SEGMENTATION
    • MARKET BY PRODUCTS 2018-2026
      • ADULT STEM CELL MARKET
        • HEMATOPOIETIC STEM CELL MARKET
        • MESENCHYMAL STEM CELL MARKET
        • NEURAL STEM CELL MARKET
        • DENTAL STEM CELL MARKET
        • UMBILICAL CORD STEM CELL MARKET
      • HUMAN EMBRYONIC STEM CELL
      • INDUCED PLURIPOTENT STEM CELL MARKET
      • RAT NEURAL STEM CELL MARKET
    • MARKET BY TECHNOLOGY 2018-2026
      • STEM CELL ACQUISITION
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS MARKET
        • UMBILICAL CORD BLOOD MARKET
      • STEM CELL PRODUCTION
        • THERAPEUTIC CLONING
        • IVF STEM CELL
        • STEM CELL CULTURE
      • STEM CELL CRYOPRESERVATION
      • STEM CELLS EXPANSION AND SUB-CULTURE
    • MARKET BY APPLICATION 2018-2026
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC (APAC)
      • INDIA
      • CHINA
      • JAPAN
      • SOUTH KOREA
      • REST OF ASIA PACIFIC (ROAPAC)
    • REST OF WORLD (ROW)
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
      • REST OF AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.